Evidence map›Paper›PMID 24733555›Full record

ArticlePloS one2014

A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes.

Madlen Pogoda, Jens B Bosse, Karl-Klaus Conzelmann, Ulrich H Koszinowski, Zsolt Ruzsics

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Madlen PogodaMax von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany; DZIF - German Center for Infection Research, Munich, Germany.
Jens B BosseMax von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
Karl-Klaus ConzelmannMax von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
Ulrich H KoszinowskiMax von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany.
Zsolt RuzsicsMax von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany; DZIF - German Center for Infection Research, Munich, Germany.
Ludwig-Maximilians-Universität München · DEGerman Center for Infection Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inactivation of gene products by dominant negative mutants is a valuable tool to assign functions to yet uncharacterized proteins, to map protein-protein interactions or to dissect physiological pathways. Detailed functional and structural knowledge about the target protein would allow the construction of inhibitory mutants by targeted mutagenesis. Yet, such data are limited for the majority of viral proteins, so that the target gene needs to be subjected to random mutagenesis to identify suitable mutants. However, for cytomegaloviruses this requires a two-step screening approach, which is time-consuming and labor-intensive. Here, we report the establishment of a high-throughput suitable screening system for the identification of inhibitory alleles of essential genes of the murine cytomegalovirus (MCMV). In this screen, the site-specific recombination of a specifically modified MCMV genome was transferred from the bacterial background to permissive host cells, thereby combining the genetic engineering and the rescue test in one step. Using a reference set of characterized pM53 mutants it was shown that the novel system is applicable to identify non-complementing as well as inhibitory mutants in a high-throughput suitable setup. The new cis-complementation assay was also applied to a basic genetic characterization of pM99, which was identified as essential for MCMV growth. We believe that the here described novel genetic screening approach can be adapted for the genetic characterization of essential genes of any large DNA viruses.

Indexed as

AllelesGenes, DominantGenes, EssentialGenes, ViralAnimalsDNA NucleotidyltransferasesGenetic Complementation TestGenetic TestingMiceMuromegalovirusMutationNIH 3T3 CellsReproducibility of ResultsViral ProteinsDNA NucleotidyltransferasesFLP recombinaseViral Proteins

Identifiers

PMID24733555
PMCPMC3986410
OpenAlexW2090679571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.